4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-046787
CFO sold 406,731 shares at an average $22.43 ($9,122,307)
- CFO acquired 260,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pulik Richard CFO | 2025-12-23 | Option exercise | +260,000 | $3.85 | $1,001,000 | 646,144 | D |
| Pulik Richard CFO | 2025-12-23 | Sale | −260,000 | $22.45 | $5,837,000 | 386,144 | D |
| Pulik Richard CFO | 2025-12-23 | Sale | −146,731 | $22.39 | $3,285,307 | 239,413 | D |
| Derivatives | |||||||
| Pulik Richard CFO | 2025-12-23 | Option exercise · Stock Option (Right to Buy) | −260,000 | 740,000 | D | ||
| Open-market sales · 406,731 sh · avg $22.43 · $9,122,307 | |||||||
Loading xslF345X05/form4.xml…